Adult Hodgkin's Lymphoma: Treatment Warning Signs
When your medical team lays out your treatment plan, they will tell you if there will be any side effects. Some side effects can be dangerous and require the attention of a doctor. You should get a list of signs you should look for from your treatment center that require medical attention or immediate treatment.
The following is a list of possible side effects which may require the prompt attention of a doctor:
#1. A fever, usually over 100.5 degrees F (38 deg. Celsius)
- Unusual fatigue
- Any infection
- Prolonged constipation or diarrhea
- Blood in the stool or urine
- Mouth or throat sores
- Excessive cough
- Shortness of breath
- Dizziness
- Unexpected weight gain or loss (10 pounds / 4 kilos or more)
- Swelling in the legs
- Tingling in your fingers or toes
- Ringing in your ears
- Red dots under your skin
- Unusual bruising or bleeding
- Nausea or vomiting despite medication
- Chest pain
- Palpitations
- Wheezing
- Intense Chills
- Pain or soreness at the chemo injection site or catheter site
Don't expect to have all these symptoms after treatment- side effects depend on the treatment you have and your health. Some treatments have few if any side effects and treatments do not affect everyone the same way.
Do ask your medical team about side effect questions and what to do before treatment. Have medical contact information (telephone numbers, etc.) readily available in case serious effects come on suddenly.
Sponsored Links
Resources
Yahoo / ACS - When do I call my doctor?
US NCI - Chemotherapy and You - Effects
Related Articles
Further Reading on Adult Hodgkin's Disease / Lymphoma:
Hodgkin's Lymphoma: ABVD Chemotherapy
Lymphoma: Peripheral Neuropathy
Adult Hodgkin's Lymphoma: Resources
Adult Hodgkin's Lymphoma: Diagnosis
Hodgkin's Lymphoma (Disease) (Main Page)
Bone Marrow and Peripheral Blood Stem Cell Transplants
For Information on Childhood Hodgkin's:
Childhood Hodgkin's Information Pages
Books
Living With Lymphoma, Elizabeth Adler, Oct. 2005
• Chapter 3: Chemotherapy, pp 78-79
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
